SCHEMBL30965337

SCHEMBL30965337

Cc1ccc(C)c(C2C(=O)Nc3ccc(Br)cc32)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.49
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.49
NQO2 P16083 1/20 0.42
LMNA P02545 3/20 0.40
AGTR1 P30556 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
TGM2 P21980 1/20 0.37
CES1 P23141 1/20 0.37
CCNB2 O95067 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29242289 1.00 TP53 (0.49) TP53MAPTPOLBNQO2LMNA
SCHEMBL29242291 0.89 MAPT (0.40) TP53MAPTPOLBNQO2AGTR1
SCHEMBL30965344 0.83 PGR (0.41) TP53MAPTPOLBALDH1A1CYP1A2
SCHEMBL29242350 0.83 PGR (0.41) TP53MAPTPOLBALDH1A1CYP1A2
SCHEMBL29242344 0.82 TP53 (0.48) TP53MAPTPOLBNQO2LMNA
SCHEMBL30965340 0.82 TP53 (0.48) TP53MAPTPOLBNQO2LMNA
SCHEMBL29242355 0.77 BRD4 (0.41) TP53MAPTPOLBALDH1A1CYP1A2
SCHEMBL30965343 0.77 BRD4 (0.41) TP53MAPTPOLBALDH1A1CYP1A2
SCHEMBL30965336 0.75 BRD4 (0.47) TP53MAPTLMNAALDH1A1KDM4E
SCHEMBL29242303 0.75 BRD4 (0.47) TP53MAPTLMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221565-A 3-Aryl indol-2-one compound with anticancer activity and application thereof in preparation of medicines for treating cancers 常州大学 2024-06-21 CN disclosed